top of page



12:00 p.m. - 2:00 p.m.


The Science & Innovation Symposium is part of the in-person event held at Staglin Family Vineyard and melds the expertise of its guest speakers with its welcoming and familial atmosphere to boost knowledge and hope for all who attend.

Information on the 2024 Scientific Symposium is not yet available.


Steve Paul, M.D.

CSO & President of Research and Development, Karuna Therapeutics.

Dr. Steve Paul is the Chief Scientific Officer, President of Research and Development, and a member of the board of directors at Karuna Therapeutics. He most recently served as Chairman of the Board, President, and Chief Executive Officer from 2018 – 2022. He is an expert in central nervous system (CNS) drug discovery and development. Dr. Paul spent 17 years at Eli Lilly and Company (NYSE: LLY), during which time he held several key leadership roles, including Executive Vice President for Science and Technology and President of the Lilly Research Laboratories. At Lilly he was responsible for the company’s overall research and development efforts and helped to oversee the development of CNS drugs such as Zyprexa® and Cymbalta® as well as the development of xanomeline where its antipsychotic and procognitive properties were initially demonstrated. Prior to Lilly, Dr. Paul spent 18 years at the National Institute of Health (NIH) and served as the Scientific Director of the National Institute of Mental Health (NIMH). Dr. Paul is a co-founder and board member of Sage Therapeutics (NASDAQ: SAGE) and a co-founder of Voyager Therapeutics (NASDAQ: VYGR) where he served as President, Chief Executive Officer. Dr. Paul is the former director of the Appel Alzheimer’s Disease Research Institute at Weill Cornell Medical College and is currently a Professor of Psychiatry and Neurology at Washington University of St. Louis School of Medicine.

Steve Paul MD Headshot_April 2023 (1).jpg
One Mind Rising Star Awards Logo_transparent.png

The 2023 One Mind Rising Star Award winners will be at the Science & Innovation Symposium to present their awarded research projects and participate in a Q&A session with those in attendance. 

One Mind is grateful for the support from the Luther, Deyo, Langford and Hall families for their generous contributions that make these awards possible.

One Mind Accelerator Logo_All Black_Stacked.png

The One Mind Accelerator backs visionary founders of early-stage startups with the network, education, and capital to rapidly build category-defining companies that improve the lives of people living with mental illness.
The inaugural 2023 program is supporting 11 early-stage companies with a $100,000 investment and 10-weeks of intensive programming designed to help founders rapidly take their companies to the next level. 



Deep Science & Tech


with the 2023 One Mind Accelerator Startups

Celine Tien
Founder & CEO, Flowly

Jacob Robinson, Ph.D
Co-Founder & CEO, Motif Neurotech, Professor, Rice University  

Emily Stern, M.D.
Co-Founder & CEO, Ceretype Neuromedicine

Lindsay Dow
Founder & CEO, Tetricus Labs

2023 Rising Star Award Winners

bottom of page